Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Croatian Medical Journal|October 29, 2002
Surgical resection in the treatment of primary gastrointestinal non-Hodgkin's lymphoma: retrospective studyIvo Radman, Jasminka Kovacević-Metelko, Igor Aurer, et al.
Acta Medica Croatica : Casopis Hravatske Akademije Medicinskih Znanosti|October 16, 2009
[Twenty years of severe aplastic anemia treatment at Department of Hematology, University Department of Medicine, Zagreb University Hospital Center, Zagreb, Croatia]Mirando Mrsić, Ranka Serventi Seiwerth, Boris Labar, et al.
Cancers|February 10, 2024
Long-Term Results of IFRT vs. ISRT in Infradiaphragmal Fields in Aggressive Non-Hodgkins's Lymphoma Patients-A Single Centre ExperienceLea Galunic Bilic, Fedor Santek, Zdravko Mitrovic, et al.
Annals of Hematology|April 23, 2016
High-dose ifosfamide and mitoxantrone (HDIM) in patients with relapsed or refractory Hodgkin's lymphomaIgor Aurer, Damir Nemet, Zdravko Mitrović, et al.
La Radiologia Medica|March 15, 2023
Efficacy and toxicity of infradiaphragmal radiotherapy fields in lymphoma patients: a single-centre experienceLea Galunic Bilic, Fedor Santek, Josip J Grah, et al.
European Journal of Haematology|March 21, 2023
Dose-adjusted EPOCH and rituximab (DA-EPOCH-R) in older patients with high-risk aggressive diffuse large B-cell lymphoma: A real-life multicenter study by the Croatian Cooperative Group for Hematologic diseases (KroHem)Zdravko Mitrovic, Dino Dujmovic, Ozren Jaksic, et al.
Hemasphere|November 21, 2022
Efficacy and Safety of Obinutuzumab-chemotherapy Combinations in Front-line Treatment of Follicular Non-Hodgkin Lymphoma During the COVID-19 Pandemic: A Study of KROHEM, the Croatian Cooperative Group for Hematologic DiseasesDavor Galusic, Sandra Basic-Kinda, Andela Pijuk, et al.
Annals of Hematology|November 20, 2020
R-CHOEP14 in younger high-risk patients with large B cell lymphoma: an effective front-line regimen with cardiac toxicity: a real-life, single-center experienceSandra Bašić-Kinda, Ivo Radman, Dino Dujmović, et al.
Blood Advances|January 8, 2025
Maximum tumor diameter is associated with relapse risk in limited-stage Hodgkin lymphoma: an international studyElizabeth H Phillips, Nicholas Counsell, Tim Illidge, et al.
Medicine|June 19, 2023
Glomerular filtration rate is an independent prognostic factor in patients with B-large cell lymphomaVedran Premužić, Sandra Bašić-Kinda, Ivo Radman, et al.
Pageof 7